Sodium borohydride → 5-[1-(2-Chlorophenyl)-6-ethoxycarbonyl-6-methylheptyl]-4,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester

HRID 1801548ノート

反応式

HRID 1801548 の反応式
[Br-].[C:2]([O:6][C:7]([N:9]1[C:17]2[CH:16]=[CH:15][N+:14]([CH:18]([C:26]3[CH:31]=[CH:30][CH:29]=[CH:28][C:27]=3[Cl:32])[CH2:19][CH2:20][CH2:21][CH2:22][CH:23]([CH3:25])[CH3:24])=[CH:13][C:12]=2[CH:11]=[CH:10]1)=[O:8])([CH3:5])([CH3:4])[CH3:3].[BH4-].[Na+]>CCO>[C:2]([O:6][C:7]([N:9]1[C:17]2[CH2:16][CH2:15][N:14]([CH:18]([C:26]3[CH:31]=[CH:30][CH:29]=[CH:28][C:27]=3[Cl:32])[CH2:19][CH2:20][CH2:21][CH2:22][C:23]([C:7]([O:6][CH2:2][CH3:3])=[O:8])([CH3:24])[CH3:25])[CH2:13][C:12]=2[CH:11]=[CH:10]1)=[O:8])([CH3:4])([CH3:5])[CH3:3]

参加物

4

反応物 2

HCID 4311764Sodium borohydride2 回HCID 696696741-tert-butoxycarbonyl-5-[1-(2-chlorophenyl)-6-methylheptyl]-1H-pyrrolo[3,2-c]pyridin-5-ium bromide

生成物 1

HCID 675180355-[1-(2-Chlorophenyl)-6-ethoxycarbonyl-6-methylheptyl]-4,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester収率 140.2%

試薬・触媒・溶媒 1

HCID 702Ethanol溶媒

実験手順

To a solution of 1-tert-butoxycarbonyl-5-[1-(2-chlorophenyl)-6-methylheptyl]-1H-pyrrolo[3,2-c]pyridin-5-ium bromide (2.4 g, 4.0 mmol) in 70% EtOH (60 mL) was added (at room temperature, with vigorous stirring, and in portions) sodium borohydride (0.30 g, 8.0 mmol). When the sodium borohydride was completely added, the stirring was terminated and mixture was stirred for 0.5 hours. The solvent was evaporated under reduced pressure and water (60 mL) was added. The product was extracted with dichloromethane (3×150 mL) and the combined organic extracts were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified by column chromatography (silica gel, ethyl acetate/heptane=1/10 to 1/3) to yield 5-[1-(2-chlorophenyl)-6-ethoxycarbonyl-6-methylheptyl]-4,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester (1.45 g, 60.9% yield) as a yellow oil. 1H NMR (Field: 300 MHz, Solvent: CD3OD/TMS) δ (ppm): 7.50 (dd, 1H, J=7.5, 1.2 Hz), 7.37 (d, 1H, J=8.1, 1.5 Hz), 7.27-7.10 (m, 3H), 5.94 (d, 1H, J=3.3 Hz), 4.16-4.13 (m, 1H), 4.09 (q, 2H, J=6.9 Hz), 3.62 (d, 1H, J=14.1 Hz), 3.28 (d, 1H, J=13.5 Hz), 2.85-2.60 (m, 4H), 1.98-1.76 (m, 2H), 1.55 (s, 9H), 1.42 (t, 2 μl, J=6.9 Hz), 1.28-1.16 (m, 4H), 1.21 (t, 3H, J=7.2 Hz), 1.11 (s, 6H). 13C NMR (Field: 75 MHz, Solvent: CDCl3/TMS) δ (ppm): 177.98, 149.49, 139.66, 134.90, 129.44, 129.15, 127.93, 127.60, 126.84, 120.92, 119.77, 109.20, 83.26, 63.76, 60.33, 48.81, 48.19, 42.30, 40.80, 33.23, 32.13, 28.31, 26.07, 25.35, 22.96, 14.52. HRMS (DART-TOF): Calculated for C29H41ClN2O2 (M+H)+: 517.2828, found 517.2833.

後処理

  1. customthe stirring was terminated
  2. customThe solvent was evaporated under reduced pressure and water (60 mL)
  3. additionwas added
  4. extractionThe product was extracted with dichloromethane (3×150 mL)
  5. dry with materialthe combined organic extracts were dried over sodium sulfate
  6. filtrationfiltered
  7. concentrationconcentrated under reduced pressure
  8. customThe crude residue was purified by column chromatography (silica gel, ethyl acetate/heptane=1/10 to 1/3)

出典と根拠

ORDレコード
ord-3bf8867e919546d0ade1daf898a6939a
出典データセット
uspto-grants-2013_01
特許番号
US08349833B2

反応ノート

読み込み中…